Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.9M | 324 | 55.2% |
| Consulting Fee | $979,222 | 171 | 28.6% |
| Travel and Lodging | $339,149 | 1,388 | 9.9% |
| Royalty or License | $130,000 | 4 | 3.8% |
| Food and Beverage | $62,531 | 1,315 | 1.8% |
| Unspecified | $23,475 | 13 | 0.7% |
| Education | $42.25 | 5 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $2.0M | 2,337 | $0 (2022) |
| ABBVIE INC. | $1.3M | 740 | $0 (2024) |
| Visant Medical, Inc. | $130,000 | 9 | $0 (2022) |
| MERZ NORTH AMERICA, INC. | $29,859 | 43 | $0 (2024) |
| Galderma Laboratories, L.P. | $20,682 | 54 | $0 (2021) |
| Nordic Pharma, Inc. | $4,999 | 1 | $0 (2024) |
| Merz Pharmaceuticals GmbH | $1,793 | 20 | $0 (2017) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $125.00 | 1 | $0 (2021) |
| Horizon Therapeutics plc | $119.06 | 1 | $0 (2021) |
| Valeant Pharmaceuticals North America LLC | $108.38 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $586,458 | 321 | ABBVIE INC. ($581,182) |
| 2023 | $644,135 | 410 | ABBVIE INC. ($635,441) |
| 2022 | $652,593 | 527 | Allergan, Inc. ($564,466) |
| 2021 | $569,356 | 637 | Allergan, Inc. ($555,293) |
| 2020 | $202,366 | 237 | Allergan, Inc. ($192,345) |
| 2019 | $364,489 | 603 | Allergan Inc. ($360,233) |
| 2018 | $296,713 | 265 | Allergan Inc. ($179,219) |
| 2017 | $109,322 | 220 | Allergan Inc. ($107,007) |
All Payment Transactions
3,220 individual payment records from CMS Open Payments — Page 1 of 129
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $957.00 | General |
| 12/30/2024 | Nordic Pharma, Inc. | Lacrifill (Device) | Consulting Fee | Cash or cash equivalent | $4,999.02 | General |
| Category: Opthalmics | ||||||
| 12/24/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $1,196.25 | General |
| 12/24/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $1,010.17 | General |
| 12/17/2024 | ABBVIE INC. | BOTOX (Biological) | Consulting Fee | Cash or cash equivalent | $1,595.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/17/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $744.33 | General |
| 12/10/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $2,153.25 | General |
| 12/10/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $20.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/03/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $31,900.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/03/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $17,500.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/03/2024 | ABBVIE INC. | BOTOX (Biological) | Consulting Fee | Cash or cash equivalent | $1,595.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/26/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $17,500.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/26/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $1,674.75 | General |
| 11/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $48.03 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $40.97 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $39.56 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/21/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $445.96 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/21/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $336.79 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/21/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $326.84 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $59.85 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/21/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $58.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/21/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $24.12 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/20/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $89.11 | General |
| 11/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: FACIAL AESTHETICS | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Prospective, evaluator-blind, multicenter study to assess the safety and effectiveness of treatment with the Octave System for lifting the eyebrow and improving the appearance of the face and neck | MERZ NORTH AMERICA, INC. | $15,000 | 1 |
| Prospective, evaluator-blind, multicenter study to assess the safety and effectiveness of treatment with the Octave System for lifting the eyebrow and improving the appearance of the face and neck | Merz North America, Inc. | $8,475 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 554 | 567 | $478,689 | $174,344 |
| 2022 | 10 | 857 | 864 | $506,861 | $181,810 |
| 2021 | 12 | 1,362 | 1,386 | $601,287 | $219,592 |
| 2020 | 14 | 1,381 | 3,523 | $626,075 | $219,414 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2023 | 215 | 215 | $373,305 | $138,351 | 37.1% |
| 67904 | Repair of tendon of upper eyelid | Facility | 2023 | 30 | 31 | $51,011 | $19,174 | 37.6% |
| 67950 | Reconstruction of eyelid margin | Facility | 2023 | 23 | 26 | $27,899 | $8,121 | 29.1% |
| 92082 | Exam of visual field with intermediate testing | Office | 2023 | 164 | 168 | $16,464 | $5,171 | 31.4% |
| 92081 | Exam of visual field with limited testing | Office | 2023 | 94 | 99 | $6,930 | $2,581 | 37.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 16 | $2,528 | $767.07 | 30.3% |
| 92285 | Photography of content of eyes | Office | 2023 | 12 | 12 | $552.00 | $179.90 | 32.6% |
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2022 | 179 | 179 | $311,281 | $117,708 | 37.8% |
| 67904 | Repair of tendon of upper eyelid | Facility | 2022 | 30 | 30 | $53,525 | $20,047 | 37.5% |
| 67966 | Removal of over 1/4 of eyelid margin and repair of eyelid | Facility | 2022 | 22 | 23 | $31,901 | $10,413 | 32.6% |
| 67950 | Reconstruction of eyelid margin | Facility | 2022 | 31 | 33 | $33,774 | $9,047 | 26.8% |
| 92082 | Exam of visual field with intermediate testing | Office | 2022 | 256 | 260 | $25,480 | $8,045 | 31.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 121 | 121 | $19,118 | $6,703 | 35.1% |
| 68320 | Repair of eyelid lining with graft from external eye | Facility | 2022 | 13 | 13 | $14,755 | $5,126 | 34.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 37 | 37 | $8,399 | $2,135 | 25.4% |
| 92285 | Photography of content of eyes | Office | 2022 | 150 | 150 | $6,900 | $1,947 | 28.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 18 | 18 | $1,728 | $639.20 | 37.0% |
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2021 | 200 | 200 | $347,220 | $133,212 | 38.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 268 | 275 | $43,450 | $18,283 | 42.1% |
| 67904 | Repair of tendon of upper eyelid | Facility | 2021 | 27 | 27 | $47,858 | $18,227 | 38.1% |
| 92082 | Measurement of field of vision during daylight conditions, intermediate examination | Office | 2021 | 294 | 295 | $28,910 | $9,812 | 33.9% |
| 67950 | Enlargement of eyelid margin | Facility | 2021 | 30 | 36 | $36,711 | $9,746 | 26.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 95 | 95 | $21,565 | $7,112 | 33.0% |
| 68320 | Repair of conjunctiva with graft from external eye | Facility | 2021 | 15 | 17 | $19,862 | $6,699 | 33.7% |
| 67966 | Removal of over one-fourth of the eyelid involving lid margin | Facility | 2021 | 15 | 15 | $20,805 | $5,800 | 27.9% |
About Dr. John Fezza, MD
Dr. John Fezza, MD is a Ophthalmology healthcare provider based in Venice, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184715187.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Fezza, MD has received a total of $3.4M in payments from pharmaceutical and medical device companies, with $586,458 received in 2024. These payments were reported across 3,220 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.9M).
As a Medicare-enrolled provider, Fezza has provided services to 4,154 Medicare beneficiaries, totaling 6,340 services with total Medicare billing of $795,161. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmic Plastic and Reconstructive Surgery
- Location Venice, FL
- Active Since 09/27/2006
- Last Updated 11/27/2023
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1184715187
Products in Payments
- BOTOX (Biological) $1.3M
- BOTOX COSMETIC (Biological) $75,483
- KYBELLA (Biological) $12,173
- Lacrifill (Device) $4,999
- Xeomin (Biological) $3,386
- XEOMIN (Biological) $789.31
- Cequa (Drug) $125.00
- TEPEZZA (Drug) $119.06
- TYRVAYA (Drug) $81.91
- Omidria (Drug) $38.01
- Rhopressa (Drug) $23.72
- Superion Indirect Decompression System (Device) $18.81
- Flarex (Drug) $15.77
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Venice
P Dee Stephenson, M.d., P.a, M.D., P.A
Ophthalmology — Payments: $595,281
Joshua Kim, Md, MD
Ophthalmology — Payments: $282,186
Dr. Priya Mathews, M.d, M.D
Ophthalmology — Payments: $234,923
Dr. Joaquin De Rojas, M.d, M.D
Ophthalmology — Payments: $106,363
Steven Kane, M.d, M.D
Ophthalmology — Payments: $64,773
Dr. David Shoemaker, Md, MD
Ophthalmology — Payments: $8,077